Astana Biomed Group, an authorized Abcam distributor in Central Asia

LysoLive™ Lysosomal Acid Lipase Assay Kit

(ab253380)

Key features and details

  • Detection method: Fluorescent

Overview

  • Product name

    LysoLive™ Lysosomal Acid Lipase Assay Kit

  • Detection method

    Fluorescent

  • Product overview

    This kit utilizes the sensitive substrate LipaGreen™ to monitor acid lipase activity in the lysosomes of live cells by flow cytometry.


    The  LysoLive™ Lysosomal Acid Lipase Assay Kit utilizes a sensitive substrate for lysosomal acid lipase (LAL), an enzyme indicated in several diseases such as Lysosomal Acid Lipase Deficiency (LALD). The substrate only becomes fluorescent upon cleavage by the enzyme meaning lysosomes with low acid lipase activity will have reduced staining in a manner proportional to the enzyme activity levels found in the cell.


    This kit is sold by Marker Gene under product code M2887.

  • Notes

    Important Licensing Information: This product may be covered by one or more United States or International Patents and is subject to our Limited Use Label Licenses. By use of this product, you accept the terms and conditions of all applicable Limited Use Label Licenses.

Properties

  • Storage instructions

    Please refer to protocols.
  • Components 1 units
    DMSO 1 x 500µl
    LysoLive™ LipaGreen 5 units
    MarkerGene™ Flow Holding and Sorting Buffer for Adherent Cells 1 x 10ml
    MarkerGene™ Flow Holding and Sorting Buffer for non-Adherent Cells 1 x 10ml

  • Research areas

  • Function

    Crucial for the intracellular hydrolysis of cholesteryl esters and triglycerides that have been internalized via receptor-mediated endocytosis of lipoprotein particles. Important in mediating the effect of LDL (low density lipoprotein) uptake on suppression of hydroxymethylglutaryl-CoA reductase and activation of endogenous cellular cholesteryl ester formation.

  • Involvement in disease

    Defects in LIPA are the cause of Wolman disease (WOD) [MIM:278000]. WOD is a severe manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. WOD occurs in infancy and is nearly always fatal before the age of 1 year.
    Defects in LIPA are the cause of cholesteryl ester storage disease (CESD) [MIM:278000]. CESD is a mild manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. It is characterized by late-onset.

  • Sequence similarities

    Belongs to the AB hydrolase superfamily. Lipase family.

  • Cellular localization

    Lysosome.
  • Information by UniProt

  • Alternative names

    • Acid cholesteryl ester hydrolase
    • CESD
    • cholesterol ester hydrolase
    • cholesterol ester storage disease
    • Cholesteryl esterase
    • Hydrolase deficiency
    • LAL
    • LAL deficiency cholesterol ester
    • LICH_HUMAN
    • lipA
    • LIPA deficiency
    • Lipase A
    • lipase A, lysosomal acid, cholesterol esterase
    • lysosomal acid lipase
    • lysosomal acid lipase deficiency
    • Lysosomal acid lipase/cholesteryl ester hydrolase
    • Sterol esterase
    see all

Images

  • Labeling cells with LysoLive Lysosomal Acid Lipase Assay Kit in healthy cells and those from a LALD patient.
    Labeling cells with LysoLive Lysosomal Acid Lipase Assay Kit in healthy cells and those from a LALD patient.
  • Labeling of healthy cells with LysoLive Lysosomal Assay Kit after treatment with Lipase inhibiter (Orlistat).
    Labeling of healthy cells with LysoLive Lysosomal Assay Kit after treatment with Lipase inhibiter (Orlistat).

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.